The management of hiv-hodgkin lymphoma

Marcus Hentrich, Michele Spina

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Hodgkin lymphoma (HL) is one of the most common non-AIDS-defining malignancies in the setting of HIV. Patients usually present with advanced-stage disease and median CD4 cell counts roughly between 150 and 250/μL. Since the introduction of combined antiretroviral therapy (cART), the prognosis of patients with HIV-HL has markedly improved. Standard curative-intent therapy and modern cART has resulted in outcomes that are similar to that reported in the general population.

Original languageEnglish
Title of host publicationHematologic Malignancies
PublisherSpringer
Pages335-347
Number of pages13
DOIs
Publication statusPublished - 2020

Publication series

NameHematologic Malignancies
ISSN (Print)2197-9766
ISSN (Electronic)2197-9774

Keywords

  • Autologous stem cell transplantation
  • Brentuximab vedotin
  • HIV
  • HIV-associated Hodgkin lymphoma
  • Hodgkin lymphoma

ASJC Scopus subject areas

  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'The management of hiv-hodgkin lymphoma'. Together they form a unique fingerprint.

Cite this